Using the same model, this group also showed that the addition of anti-VEGF antibodies increased the number and activity of DC in mice implanted with subcutaneous tumours (D459 and MethA sarcoma), although without any therapeutic effect on tumour growth (Gabrilovich et al, 1999). This evidence concerns the gene VEGFA and neoplasm.